AI-Powered drug development


Background PathAI
PathAI Andy Beck, Co-Founder & CEO of PathAI

PathAI’s mission is to improve patient outcomes with AI-powered pathology. Their platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning.


8 VC, General Catalyst, General Atlantic